Nikhil Lalwani

CEO · ANI PHARMACEUTICALS INC

Rank #3,173 SEC EDGAR (United States) ↗ Files from United States

Details

Officer and board memberPharmaceuticals & BiotechnologyANIPSEC CIK 0001822629

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$28.8M
1-day change
▼ 1.06%
Positions on file
1
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$28.5M – $39.6M2026-09-04

Insider activity May 14, 2024 – Mar 7, 2026

Nikhil Lalwani is recorded in filings to the U.S. SEC via EDGAR as officer and board member, and reported 18 transactions between May 14, 2024 and Mar 7, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$7.94M
4 sales on file priced rows only
All reported transactions
18
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 20 most recent rows are grouped into 18 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. ANI PHARMACEUTICALS INC ANIP S Open-market sale 5,400 shares $401.2K at $74.30 SEC filing ↗
  2. ANI PHARMACEUTICALS INC ANIP S Open-market sale 55,000 shares $4.27M at $77.57 SEC filing ↗
  3. ANI PHARMACEUTICALS INC ANIP F Shares withheld for taxesnot a buy/sell decision 17,060 shares $1.26M at $74.04 SEC filing ↗
  4. ANI PHARMACEUTICALS INC ANIP F Shares withheld for taxesnot a buy/sell decision 12,217 shares $902.8K at $73.90 SEC filing ↗
  5. ANI PHARMACEUTICALS INC ANIP A Grant or awardnot a buy/sell decision 75,592 shares $5.83M at $77.15 SEC filing ↗
  6. ANI PHARMACEUTICALS INC ANIP F Shares withheld for taxesnot a buy/sell decision 10,298 shares $796.7K at $77.36 SEC filing ↗
  7. ANI PHARMACEUTICALS INC ANIP F Shares withheld for taxesnot a buy/sell decision 11,688 shares $896.5K at $76.70 SEC filing ↗
  8. ANI PHARMACEUTICALS INC ANIP F Shares withheld for taxesnot a buy/sell decision 30,659 shares $2.34M at $76.25 SEC filing ↗
  9. ANI PHARMACEUTICALS INC ANIP S Open-market sale 56,960 shares $4.89M at $85.93 SEC filing ↗
  10. ANI PHARMACEUTICALS INC ANIP F Shares withheld for taxesnot a buy/sell decision 17,455 shares $1.12M at $64.26 SEC filing ↗
  11. ANI PHARMACEUTICALS INC ANIP F Shares withheld for taxesnot a buy/sell decision 17,060 shares $1.03M at $60.62 SEC filing ↗
  12. ANI PHARMACEUTICALS INC ANIP F Shares withheld for taxesnot a buy/sell decision 12,216 shares $756.0K at $61.89 SEC filing ↗
  13. ANI PHARMACEUTICALS INC ANIP F Shares withheld for taxesnot a buy/sell decision 7,799 shares $459.5K at $58.92 SEC filing ↗
  14. ANI PHARMACEUTICALS INC ANIP A Grant or award × 2not a buy/sell decisionreported at zero 152,331 shares $0
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    60,932 $0.00reported at zero $0 SEC filing ↗
    91,399 $0.00reported at zero $0 SEC filing ↗
  15. ANI PHARMACEUTICALS INC ANIP S Open-market sale × 2 33,481 shares $1.94M
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    3,481 $58.30 $202.9K SEC filing ↗
    30,000 $57.95 $1.74M SEC filing ↗
  16. ANI PHARMACEUTICALS INC ANIP M Option exercise or conversionnot a buy/sell decision 30,000 shares $870.0K at $29.00 SEC filing ↗
  17. ANI PHARMACEUTICALS INC ANIP F Shares withheld for taxesnot a buy/sell decision 3,646 shares $220.6K at $60.51 SEC filing ↗
  18. ANI PHARMACEUTICALS INC ANIP S Open-market sale 16,669 shares $1.10M at $66.10 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
ANI PHARMACEUTICALS INC ANIP Common Stock 404,889 $71.23 $28.8M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Nikhil Lalwani reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.